Fibrinogen Concentrate Market Report

Fibrinogen Concentrate Market Report

Fibrinogen Concentrate Market Report
Report code - SR1169 Delivery - 2 Weeks
Fibrinogen Concentrate Market Size, Share, Trends, Dynamics, Forecast, & Growth A See more...

Market Insights

"The global fibrinogen concentrate market size was estimated at USD 2.79 billion in 2021 and is likely to grow at a CAGR of 5.53% during 2022-2028 to reach USD 4.09 billion by 2028."

Fibrinogen-Concentrate-Market-Insights

Wish to get a free sample? Click Here.

Fibrinogen concentrate is defined as a blood coagulation factor used in the treatment of acute bleeding episodes in patients who have congenital fibrinogen deficiency including afibrinogenemia and hypofibrinogenemia. Fibrinogen concentrate can be categorized as human fibrinogen concentrates and animal fibrinogen concentrates.

Fibrinogen Concentrate Market Report Overview

Market Size in 2028

USD 4.09 Billion

Market Size in 2021

USD 2.79 Billion

Market Growth (2022-2028)

CAGR of 5.53%

Base Year of Study

2021

Trend Period

2016-2020

Forecast Period

2022-2028

Market Dynamics

Market Drivers

The growth of the market is primarily driven by:

  • Rising incidences of blood related disorders due to stress and changing lifestyle.
  • Increasing use of fibrinogen concentrate to treat congenital deficiencies is likely to propel the global fibrinogen concentrate market progress at a significant rate during the review period.
  • In addition to this, increasing investment in research and development activities is likely to create lucrative opportunities for the players operating in the global market in the coming years.

Latest Trends

The fibrinogen concentrate market is expected to experience significant growth due to the increasing prevalence of hemophilia and advancements in fibrinogen-related products. With more than 350,000 hemophilia cases and more than 70% of affected individuals not receiving proper treatment, the market is expected to grow.

A 2019 review by the Journal of Apoplexy and Haemostasis, Fibclot and Clottafact found that human fibrinogen concentrate is effective in treating patients with fibrinogen deficiency. The increasing prevalence of hemophilia and the safety and efficacy of human fibrinogen concentrate are expected to drive market development in this area.

Restraining Factors

Fibrinogen concentrate can cause side effects like chills, fever, sickness, and heaving, which can be severe. Adverse effects include anaphylactic reactions, which can be a sensitivity side effect or first signs of touchiness. If these reactions occur, it is crucial to stop using the drug immediately.

In patients with inborn fibrinogen deficiency, apoplexy can occur both with and without fibrinogen substitution treatment. Patients receiving fibrinogen concentrate may also experience pneumonic embolism, myocardial localized necrosis, deep vein apoplexy, and blood vessel apoplexy signs and side effects.

COVID-19 Impact

The Covid-19 outbreak posed significant challenges on the healthcare sector across geographies. It impacted the progress of the market negatively as only essential and emergency healthcare services were being provided in the hospitals and thus, affected the market progress for a short period of time.

Segments Analysis

Segmentations

List of Sub-Segments

Dominant and Fastest-Growing Segments

Type Analysis

Human Fibrinogen Concentrates, Animal Fibrinogen Concentrates

The forecasted period's largest segment share is expected to be human fibrinogen concentrate.

Application Analysis

Hospitals, Ambulatory Surgical Centers, Others

The hospitals segment accounted for the largest market share in 2021 and is projected to register significant growth during the forecast period.

Regional Analysis

North America, Europe, Asia-Pacific, Middle East and Africa, and South America

North America accounted for the largest market share in 2021 and is projected to grow at a significant CAGR during the assessment period.

By Type

"The human fibrinogen concentrates segment accounted for the largest market share."

The market has been bifurcated into human fibrinogen concentrates, animal fibrinogen concentrates. The forecasted period's largest segment share is expected to be human fibrinogen concentrate, driven by the growing demand for fibrinogen concentrate for treating bleeding disorders and congenital coagulation deficiencies.

Application Trends

"The hospitals segment accounted for the largest market share."

The market has been bifurcated into hospitals, ambulatory surgical centers and others. Under these, the hospitals segment accounted for the largest market share in 2021 and is projected to register significant growth during the review period on account of presence of established healthcare infrastructure and professional healthcare staff.

Regional Insights

"North America accounted for the largest market share."

The market in North America accounted for the largest market share in 2021 and is projected to grow at a significant CAGR during the assessment period. The regional growth can be attributed to increasing incidences of blood related disorders and presence of key market players such as Thermo Fisher Scientific (The U.S) and Cayman Chemical Company (The U.S). The market progress in Asia-Pacific region is expected to be driven by increasing use of fibrinogen concentrate in treating congenital deficiencies.

Fibrinogen-Concentrate-Market-Regional-Insights

To know high-growth countries in this report, Register Here.

Key Players

The following are the key players in the fibrinogen concentrate market (arranged alphabetically).

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Report Features

This report provides intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the dynamics and will enable strategic decision-making for the existing players as well as those willing to enter the fibrinogen concentrate market.

What Deliverables Will You Get in this Report?

Key questions this report answers

Relevant contents in the report

How big is the sales opportunity?

In-depth analysis of the Fibrinogen Concentrate Market

How lucrative is the future?

The market forecast and trend data and emerging trends

Which regions offer the best sales opportunities?

Global, regional and country-level historical data and forecasts

Which are the most attractive market segments?

Market segment analysis and Forecast

Which are the top players and their market positioning?

Competitive landscape and Market share analysis

How complex is the business environment?

Porter’s five forces, PEST and Life cycle analysis

What are the factors affecting the market?

Drivers & challenges

Will I get the information on my specific requirement?

10% free customization

Research Methodology

This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s fibrinogen concentrate market realities and future market possibilities for the forecast period. The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for the market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate the growth strategies to expedite their growth process.

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Customization Options

Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

  • Detailed profiling of additional market players (up to 3 players).
  • SWOT analysis of key players (up to 3 players).

Competitive Benchmarking

  • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

Frequently Asked Questions (FAQs)

Fibrinogen concentrate is defined as a blood coagulation factor used in the treatment of acute bleeding episodes in patients who have congenital fibrinogen deficiency including afibrinogenemia and hypofibrinogenemia. Fibrinogen concentrate can be categorized as human fibrinogen concentrates and animal fibrinogen concentrates.

The fibrinogen concentrate market is expected to grow at a CAGR of 5.53 % during the upcoming five years.

Increasing use of fibrinogen concentrate to treat congenital deficiencies is likely to propel the market progress at a significant rate during the review period. In addition to this, increasing investment in research and development activities is likely to create lucrative opportunities for the players operating in the global market in the coming years.

The fibrinogen concentrate market size is estimated to grow from USD 2.79 Bn in 2021 to USD 4.09 Bn by 2028.

North America is expected to largest share of the market during the assessment period.

The LFB group (France), Green Cross Corporation (South Korea), Octapharma AG (Switzerland), Thermo Fisher Scientific (The U.S), The Merck Group (Germany), Affinity Biologicals Inc (Canada), Cayman Chemical Company (The U.S), Molecular Innovations (The U.S), CSL Limited (Australia), AkronBiotech (The U.S), Enzo Life Sciences, Inc. (The U.S) and Bovogen Biologicals Pty Ltd. (Australia). are the key companies in the market.

The hospitals segment has the largest share of the market during the estimated time.

The study period of the market is 2016-2028.